These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39421536)

  • 1. Case report: A novel
    Chandran S; Verma D; Rajadurai VS; Yap F
    Front Endocrinol (Lausanne); 2024; 15():1471596. PubMed ID: 39421536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia.
    Chandran S; R PR; Mei Chien C; Saffari SE; Rajadurai VS; Yap F
    Arch Dis Child Fetal Neonatal Ed; 2022 Jul; 107(4):359-363. PubMed ID: 34544689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Watchful waiting versus pharmacological management of small-for-gestational-age infants with hyperinsulinemic hypoglycemia.
    Chandran S; Jaya-Bodestyne SL; Rajadurai VS; Saffari SE; Chua MC; Yap F
    Front Endocrinol (Lausanne); 2023; 14():1163591. PubMed ID: 37435482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Neurodevelopmental Outcome in a Small-for-Gestational-Age Infant With Symptomatic Hyperinsulinemic Hypoglycemia, Gaze Preference, and Infantile Spasms.
    Chandran S; Teoh KW; Janardhan K; Yap F
    Front Endocrinol (Lausanne); 2022; 13():818252. PubMed ID: 35721755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A.
    Stanescu DE; Hughes N; Kaplan B; Stanley CA; De León DD
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E2026-30. PubMed ID: 22802087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous Insulin Receptor
    Sethi A; Foulds N; Ehtisham S; Ahmed SH; Houghton J; Colclough K; Didi M; Flanagan SE; Senniappan S
    J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):420-426. PubMed ID: 31989990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations.
    Flanagan SE; Kapoor RR; Mali G; Cody D; Murphy N; Schwahn B; Siahanidou T; Banerjee I; Akcay T; Rubio-Cabezas O; Shield JP; Hussain K; Ellard S
    Eur J Endocrinol; 2010 May; 162(5):987-92. PubMed ID: 20164212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diazoxide toxicity in a child with persistent hyperinsulinemic hypoglycemia of infancy: mixed hyperglycemic hyperosmolar coma and ketoacidosis.
    Mangla P; Hussain K; Ellard S; Flanagan SE; Bhatia V
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):943-945. PubMed ID: 29958183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of neonatal onset hyperinsulinemic hypoglycemia: a single neonatal center experience.
    Bezirganoglu H; Okur N; Celik K; Tas FF; Ozbek MN
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2272014. PubMed ID: 37860935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical hypoglycaemia associated with diazoxide therapy for hyperinsulinaemic hypoglycaemia.
    Ponmani C; Gannon H; Hussain K; Senniappan S
    Horm Res Paediatr; 2013; 80(2):129-33. PubMed ID: 23886961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable phenotypes of individual and family monogenic cases with hyperinsulinism and diabetes: a systematic review.
    Perge K; Nicolino M
    Rev Endocr Metab Disord; 2022 Oct; 23(5):1063-1078. PubMed ID: 35996042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel
    Chandran S; Rajadurai VS; Hoi WH; Flanagan SE; Hussain K; Yap F
    Front Pediatr; 2020; 8():320. PubMed ID: 32670997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D
    J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic heterogeneity of HNF4A/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia.
    McGlacken-Byrne SM; Mohammad JK; Conlon N; Gubaeva D; Siersbæk J; Schou AJ; Demirbilek H; Dastamani A; Houghton JAL; Brusgaard K; Melikyan M; Christesen H; Flanagan SE; Murphy NP; Shah P
    Eur J Endocrinol; 2022 Feb; 186(4):417-427. PubMed ID: 35089870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation.
    Vieira TC; Bergamin CS; Gurgel LC; Moisés RS
    Pediatr Diabetes; 2010 Nov; 11(7):505-8. PubMed ID: 20042013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom.
    Chen SC; Dastamani A; Pintus D; Yau D; Aftab S; Bath L; Swinburne C; Hunter L; Giardini A; Christov G; Senniappan S; Banerjee I; Shaikh MG; Shah P
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):770-775. PubMed ID: 31520536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hyperinsulinism due to mutations in HNF1A.
    Yau D; Colclough K; Natarajan A; Parikh R; Canham N; Didi M; Senniappan S; Banerjee I
    Eur J Med Genet; 2020 Jun; 63(6):103928. PubMed ID: 32325224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
    Davidov AS; Elkon-Tamir E; Haham A; Shefer G; Weintrob N; Oren A; Lebenthal Y; Mandel D; Eyal O
    Eur J Pediatr; 2020 Apr; 179(4):597-602. PubMed ID: 31863303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.
    Rozenkova K; Malikova J; Nessa A; Dusatkova L; Bjørkhaug L; Obermannova B; Dusatkova P; Kytnarova J; Aukrust I; Najmi LA; Rypackova B; Sumnik Z; Lebl J; Njølstad PR; Hussain K; Pruhova S
    J Clin Endocrinol Metab; 2015 Dec; 100(12):E1540-9. PubMed ID: 26431509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations.
    Tung JY; Boodhansingh K; Stanley CA; De León DD
    Pediatr Diabetes; 2018 Aug; 19(5):910-916. PubMed ID: 29493090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.